HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuo Kinoshita Selected Research

propylene dichloride

1/2022Transcriptome analysis of human cholangiocytes exposed to carcinogenic 1,2-dichloropropane in the presence of macrophages in vitro.
10/20211,2-Dichloropropane induces γ-H2AX expression in human cholangiocytes only in the presence of macrophages.
1/2019Exposure to 1,2-Dichloropropane Upregulates the Expression of Activation-Induced Cytidine Deaminase (AID) in Human Cholangiocytes Co-Cultured With Macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuo Kinoshita Research Topics

Disease

15Neoplasms (Cancer)
01/2015 - 05/2002
4Cholangiocarcinoma
01/2022 - 03/2008
4Stomach Neoplasms (Stomach Cancer)
12/2010 - 01/2003
3Hemorrhage
02/2021 - 02/2015
3Inflammation (Inflammations)
04/2016 - 03/2008
3Carcinogenesis
07/2014 - 03/2008
3Leukemia
01/2011 - 04/2006
3Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
05/2007 - 05/2003
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 09/2008
2Adenocarcinoma
08/2021 - 01/2003
2Hepatocellular Carcinoma (Hepatoma)
11/2017 - 02/2007
2Metaplasia
01/2015 - 01/2015
2Lung Injury
01/2015 - 01/2015
2Genetic Translocation (Chromosomal Translocation)
04/2006 - 05/2003
2Lymphoma (Lymphomas)
02/2006 - 05/2003
2Carcinoma (Carcinomatosis)
01/2003 - 11/2002
1Bile Duct Neoplasms (Bile Duct Cancer)
01/2022
1Hammer Toe Syndrome (Hammer Toe)
01/2022
1Foot Deformities (Foot Deformity)
01/2022
1Hyperlipidemias (Hyperlipidemia)
02/2021
1Hypertension (High Blood Pressure)
02/2021
1Polyps
02/2021
1Drug Eruptions (Drug Eruption)
04/2020
1Skin Neoplasms (Skin Cancer)
04/2016
1Hepatitis
03/2015
1Diabetes Mellitus
02/2015
1Genomic Instability
07/2014
1Insulin Resistance
03/2013
1Abdominal Obesity
03/2013
1Liver Diseases (Liver Disease)
03/2013
1Fatty Liver
03/2013
1Hiatal Hernia
12/2011
1Gastroesophageal Reflux (GERD)
12/2011
1Esophagitis
12/2011
1Gastritis
08/2011
1Duodenitis
08/2011
1Obesity
08/2011
1Colitis-Associated Neoplasms
09/2008
1Ulcerative Colitis
09/2008
1Colorectal Neoplasms (Colorectal Cancer)
09/2008
1Rupture
05/2008
1Cataract (Cataracts)
05/2008
1Genetic Predisposition to Disease (Genetic Predisposition)
03/2008
1Infections
04/2007
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2005
1T-Cell Lymphoma (Lymphoma, T Cell)
03/2005
1Small Cell Carcinoma
09/2004

Drug/Important Bio-Agent (IBA)

12Cytidine DeaminaseIBA
01/2019 - 04/2006
5Proteins (Proteins, Gene)FDA Link
07/2014 - 01/2003
4CytokinesIBA
07/2014 - 03/2008
3propylene dichlorideIBA
01/2022 - 01/2019
3AdiponectinIBA
03/2013 - 08/2011
3EnzymesIBA
03/2008 - 01/2003
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 03/2008
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
02/2021 - 04/2020
2Pharmaceutical PreparationsIBA
04/2020 - 03/2015
2DNA (Deoxyribonucleic Acid)IBA
12/2010 - 03/2008
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2007 - 09/2003
2Imatinib Mesylate (Gleevec)FDA Link
08/2005 - 05/2003
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2005 - 05/2003
1SolventsIBA
01/2022
1Botulinum Toxins (Botulinum Toxin)IBA
01/2022
1Bevacizumab (Avastin)FDA Link
08/2021
1Biomarkers (Surrogate Marker)IBA
08/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021
1Dihydrotachysterol (AT 10)IBA
02/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2020
1Clopidogrel (Plavix)FDA Link
04/2020
11- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
04/2020
1CarcinogensIBA
01/2019
1Epithelial Cell Adhesion MoleculeIBA
11/2017
1Keratin-14 (Keratin 14)IBA
07/2014
1AcidsIBA
12/2011
1Transcription Factors (Transcription Factor)IBA
01/2011
1Interleukin-13IBA
09/2008
1Interleukin-4 (Interleukin 4)IBA
09/2008
1GuanineIBA
05/2008
1I-kappa B KinaseIBA
03/2008
1NF-kappa B (NF-kB)IBA
03/2008
1Transforming Growth Factor beta (TGF-beta)IBA
02/2007
1Aspartic Acid (Aspartate)FDA Link
02/2006
1Tyrosine Kinase InhibitorsIBA
08/2005
1Chromogranin AIBA
09/2004
1Mucin-1 (CA 15-3 Antigen)IBA
09/2004
1VimentinIBA
09/2004
1Keratins (Keratin)IBA
09/2004
1Fluorouracil (Carac)FDA LinkGeneric
09/2003
1Methotrexate (Mexate)FDA LinkGeneric
09/2003
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
09/2003
1Leucovorin (Folinic Acid)FDA Link
09/2003
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2003
1Epirubicin (Ellence)FDA LinkGeneric
09/2003

Therapy/Procedure

5Drug Therapy (Chemotherapy)
08/2021 - 11/2002
5Therapeutics
04/2020 - 07/2003
2Surgical Instruments (Clip)
02/2021 - 03/2011
1Renal Dialysis (Hemodialysis)
02/2015
1Endoscopic Hemostasis
02/2015
1Blood Transfusion (Blood Transfusions)
02/2015
1Neoadjuvant Therapy
09/2003